A multicenter, prospective, observational study of warfarin-associated intracerebral hemorrhage: The SAMURAI-WAICH study.
Abstract | BACKGROUND: METHODS: WAICH patients admitted within 3 days of onset were prospectively enrolled in 10 stroke centers. Thromboembolic and hemorrhagic complications and functional outcomes were followed-up for one year. RESULTS: Of 50 WAICH patients (31 men, 73 ± 9 years old) enrolled, all stopped warfarin on admission. Elevated prothrombin time-international normalized ratios (PT-INR) were normalized in 43 (86%). Anticoagulant therapy was resumed with intravenous full-dose unfractionated heparin followed by warfarin in 9 (18%), intravenous low-dose unfractionated heparin followed by warfarin in 14 (28%) and warfarin alone in 14 (28%) at a median of 2.5 (IQR 1.25-9), 4 (2-5.5) and 6 (3-11) days after onset, respectively, after emergent admission. Onset-to-admission time (per 1-hour increase; OR 0.55, 95% CI 0.19-0.84) was inversely associated with hematoma expansion. Anticoagulant therapy was resumed with intravenous full-dose unfractionated heparin in 9 (18%), low-dose heparin in 14 (28%) and warfarin alone in 14 (28%) at a median of 2.5, 4 and 6 days after onset, respectively. During one-year follow-up (n=47), 11 thromboembolic and 6 hemorrhagic complications were documented. Twenty four patients showed unfavorable outcomes, corresponding to a modified Rankin Scale score of 4-6. Thromboembolic complications (OR, 10.62; 95% CI, 1.05-227.85), as well as advanced age (per 1 year; OR, 1.27; 95% CI, 1.10-1.61) and higher National Institutes of Health Stroke Scale (NIHSS) score (per 1 point; OR, 1.24; 95% CI 1.07-1.55), were independently associated with unfavorable outcome. CONCLUSIONS: PT-INR normalization on admission and early anticoagulant resumption were common in WAICH patients. Thromboembolic complications were independently associated with unfavorable outcome.
|
Authors | Masato Osaki, Masatoshi Koga, Koichiro Maeda, Yasuhiro Hasegawa, Jyoji Nakagawara, Eisuke Furui, Kenichi Todo, Kazumi Kimura, Yoshiaki Shiokawa, Yasushi Okada, Satoshi Okuda, Kazuomi Kario, Hiroshi Yamagami, Kazuo Minematsu, Takanari Kitazono, Kazunori Toyoda, Stroke Acute Management with Urgent Risk-factor Assessment and Improvement Study Investigators |
Journal | Journal of the neurological sciences
(J Neurol Sci)
Vol. 359
Issue 1-2
Pg. 72-7
(Dec 15 2015)
ISSN: 1878-5883 [Electronic] Netherlands |
PMID | 26671089
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Elsevier B.V. All rights reserved. |
Chemical References |
|
Topics |
- Aged
- Aged, 80 and over
- Anticoagulants
(therapeutic use)
- Cerebral Hemorrhage
(complications, drug therapy)
- Cohort Studies
- Female
- Hematoma
(etiology)
- Humans
- Male
- Middle Aged
- Observation
- Tomography, X-Ray Computed
- Treatment Outcome
- Warfarin
(therapeutic use)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|